chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Sore arm around 6 hours post-shot; Fever; headache; body aches; fatigue; chills around 12 hours post-shot; This is a spontaneous report from a non-contactable consumer or other non hcp. A 23-years-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, Batch/Lot Number: EL3247), via an unspecified route of administration, administered in Arm Left on 25Feb2021 at 14:30 (at the age of 23-years-old) as dose 2, single for covid-19 immunisation. Medical history included Shellfish (known allergies: Shellfish). The concomitant medications were not reported. The patient received first dose of bnt162b2 on 03Feb2021 at 09:30 AM (left arm, lot number: EL3247) for covid-19 immunisation. The patient was not diagnosed with COVID-19 prior to vaccination. The patient was not tested for COVID-19 since the vaccination. On 25Feb2021 at 03:00 AM the patient experienced Sore arm around 6 hours post-shot, Fever, headache, body aches, fatigue and chills around 12 hours post-shot. Therapeutic measures were taken as a result of Sore arm around 6 hours post-shot, Fever, headache, body aches, fatigue and chills around 12 hours post-shot. The adverse event treatment included Tylenol. It was reported that the events Lasted 24 hours. The outcome of all events were resolved on 2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.
7/10/03 ? mother ? Rt thigh at injection site c/o discomfort ? at 3pm on 7/10/03. Taken Dr. Child to ? as per mother on 7/16/03. ? improved 7/11/03.
Initial report received on 23 October 2006 from a health care professional. A three-year-old male patient, with no past medical history, had received a fourth dose, intramuscular, right thigh injection of Fluzone No Preservative 2006-2007, lot number U2166KA, on 21 October 2006. Six hours later, the patient developed large hive like patches between his neck and knees and throughout his trunk area. The welts were also on his arms. The welts were large, raised, itchy bumps occurring in patches (patches were four to eight inches in diameter). His eating was slightly decreased. The parents spoke with the pediatrician on the phone. The event did not require examination by the physician. The patient was treated with Claritin, Benadryl, and an oatmeal bath. The patient recovered from the event. Follow-up received on 21 November 2006 from a health care professional. The patient had no illness at the time of vaccination. As per the reporter, there was no diagnosis for the event, as the patient was not seen by a physician. Further information is not anticipated.
Mild sore arm; fatigue; A spontaneous report was received from a consumer concerning a 73-year-old, female patient who received Moderna's COVID-19 Vaccine, and who experienced a mild sore arm and fatigue.   The patient's medical history was not provided. Concomitant product use was not provided by the reporter.   On 07-Jan-2021, approximately one day prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (LOT 011L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.   Patient's husband reported that she received her Moderna vaccine on 07-Jan-2021 at 0830.  On 08-Jan-2021, he reported that she experienced a mild sore arm and fatigue.  He stated that both of those symptoms resolved later that same day.     Treatment information was not provided.   Action taken with mRNA-1273 in response to the events, a mild sore arm and fatigue, was not provided.   The events, a mild sore arm and fatigue, were considered recovered/resolved on 08-Jan-2021.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
mom states that pt cried excessively for most of the evening, noc, & following day; lt thigh site was red & swollen; crying not relieved w/APAP;
For about 3 days, moderate soreness in area of injection, redness and slight swelling in area of injection For a few hours on evening of second day (11/20), fatigue and mild chills  No treatment - I probably should have taken ibuprofen, but it wasn't that bad
This case was reported by a pharmacist via call center representative and described the occurrence of injection site lump in a 62-year-old female patient who received SHINGRIX (batch number FZ3ND, expiry date 2nd February 2021) for prophylaxis. On an unknown date, the patient received SHINGRIX. On an unknown date, immediately after receiving SHINGRIX, the patient experienced injection site lump, skin nodule and skin tenderness. On an unknown date, the outcome of the injection site lump was recovered/resolved and the outcome of the skin nodule was not recovered/not resolved and the outcome of the skin tenderness was unknown. It was unknown if the reporter considered the injection site lump, skin nodule and skin tenderness to be related to SHINGRIX. Additional details were provided as follows: The healthcare professional reported after receipt of SHINGRIX the patient developed a lump at the injection site which went away after rubbing it for a few hours (per patient). The patient then developed a lump on her clavicle a few hours later (same side) approximately a half dollar in size, not red or warm to the touch and only tender if she pressed on it.
Developed Fever of 105 at 12:30 am - fever finally to 99.7 at 4:00am; chills, body aches, severe lethargy. Sunday 3/7/2021 devleoped knot on arm that has sever burning sensation, hot to touch. Monday 3/8/2021 a fever blister developed on mouth; Tuesday 3/9/2021 - knot still there- Urgent Care visit diagnosed cellulitis - dr stated a puss pocket could be seen under skin and knot on arm size of two quarters.
difficulty hearing; headache; pain in neck/shoulder area; pain in neck/shoulder area; unusual severe pressure around upper rib cage increasing over two days; This is a spontaneous report from a contactable consumer (patient).   An 82-years-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), via an unspecified route of administration, administered in Arm Right on an unknown date in Feb2021 at 15:45 as single dose for COVID-19 immunization. Patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), via an unspecified route of administration, administered on an unknown date in Jan2021 at 03:45 PM, as single dose for COVID-19 immunization. The patient medical history was not reported. The concomitant medications included furosemide (LASIX [FUROSEMIDE]) and omeprazole (PROTONIX [OMEPRAZOLE]). The patient had reported allergy with shingles vaccine. Patient not received other vaccines within 4 weeks prior to the COVID vaccine. The patient not tested for COVID-19 since the vaccination. On 07Feb2021 at 09:00 the patient experienced difficulty hearing, headache, pain in neck/shoulder area and unusual severe pressure around upper rib cage increasing over two days. The outcome of event was recovered on an unknown date in 2021. No treatment received for the adverse event.  Information on the lot/batch number has been requested.
Day after vaccines given, (R) deltoid became red and swollen and (R) eye became red with drainage. Day 4, arm swelling and redness decreased, but eye redness worsened. Seen by ophthalmologist and diagnosed w/ iritis (R) eye - it improved at f/u but appeared in (L) eye several weeks later around 3/5/14 - pt is still following up w/ ophthalmologist.
Chills; Hot-cold flashes; This case was reported by a physician via call center representative and described the occurrence of chills in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st received on October 2019).   In January 2020, the patient received the 2nd dose of Shingrix. On an unknown date, less than 9 months after receiving Shingrix, the patient experienced chills and feeling hot and cold. On an unknown date, the outcome of the chills and feeling hot and cold were not recovered/not resolved.   The reporter considered the chills and feeling hot and cold to be related to Shingrix.  Additional details were provided as follows: A physician reported that a patient completed the series of Shingrix with 2 doses: October 2019 and January 2020.  The patient had complained of chills/hot-cold flashes and believes the symptoms are attributable to the vaccine.  The patient had seen an endocrinologist, lab-work was performed, no specific cause had been identified.
Patient came in for vaccines. Vaccine given were Hep B, BOOSTRIX, IPV, MMR, varicella and HPV. After vaccines were applied patient started getting pale not responding to questions or voice and had blank stare. Course time was 17 minutes in office. EMS was called and was taken to ER.
21 hours - headache 24 hours - muscle and joint aches, severe cramping in lower back 26 hours - chills and shaking 34 hours - severe sweating but most other symptoms had stopped. Covid arm! Red, swollen rash that is hot to touch 48 hours - Covid arm. Rash, hot, sore, swollen painful glands in same armpit and collarbone. Wrists and ankles still sore.
Soreness at injection site as well as anterior shoulder pain. Soreness at injection site resolved., but continues to have anterior shoulder pain.
herpes zoster; Information has been received regarding a case in litigation from a lawyer concerning a currently 53 year old female patient. Her medical history, concurrent conditions and concomitant medications were not reported.     On or about 01-AUG-2017, the pt was vaccinated with a dose of zoster vaccine live(ZOSTAVAX) for the prevention of shingles and zoster-related conditions (Strength, dose, route of administration, lot # and expiration date were not reported).        On an unknown date, Plaintiff was treated by a healthcare provider for the following injuries resulting from Plaintiff's zoster vaccine live(ZOSTAVAX) use: herpes zoster. Plaintiff bring this action on behalf of herself, claiming damages as a result of injury to herself, loss of consortium, loss of services and economic losses.  The outcome of herpes zoster was unknown.    The reporter considered herpes zoster to be related to Zoster Vaccine Live(ZOSTAVAX).
Child had cough, fever, runny nose and rash 7-10 days after vaccination. No treatment given.
Patient received pediatric dosage of Hepatitis B Engerix B vaccine (10mcg/0.5mL) rather than indicated dosage of 20mcg/1mL. Patient experienced no adverse effects as a result of this error.
Red knots that hurts and is itchy. Feels like I am being pinched. the actual site of injection is bruised, but the red knots are just under it.
IRRITATED EYES, PALPITATIONS, FEVER, MUSCULAR DISCOMFORT, TWO MONTHS LATER I  DEVELOPED SUDDEN DEAFNESS RIGHT EAR AND I HAVE NEVER SUFFERED FROM THE EARS, NOW MY EARS ARE NOT THE SAME
EVENTS:  1. BEGAN MENSTRUAL PERIOD HOURS AFTER 2ND DOSE OF SHOT WAS ADMINISTERED. NOTICEABLE DROPS OF BLOOD NOTICED IN BOWL OF TOILET AND SPOTTING CONTINUED FOR APPROX 2 DAYS AFTER THE BLEEDING BEGAN. I CURRENTLY HAVE AN IUD AND HAVE NOT HAD A PERIOD IN OVER 1.5 YEARS AND THAT WAS ONLY WHEN MY OLD IUD WAS REMOVED AND THE NEW ONE WAS INSERTED. BEFORE THAT, I HAD NOT HAD A PERIOD IN OVER 4 YEARS. I HAD NOT HAD ANY EXAMS OR SEXUAL CONTACT/INTERCOURSE WITHIN THE PAST 3 MONTHS THAT COULD ACCOUNT FOR THE BLEEDING.  2. VERY PAINFUL CRAMPING IN LOWER ABDOMEN/ UTERUS AREA. BEGAN THE DAY AFTER RECEIVING THE 2ND DOSE AND HAVE CONTINUED ON AND OFF INTERMITTENLY SINCE. STILL OCCURING CURRENTLY  3. EXTREME RIGHT ARM PAIN DAYS 2 & 3 AFTER RECEIVING THE SHOT. COULD NOT MOVE SHOULDER WITHOUT EXCRUCIATING PAIN IN THE SHOULDER AREA. HAS SINCE RESOLVED.  4. MODERATE TO SEVER FLU LIKE SYMPTOMS FROM @ 1AM 01/27- 8PM 01/27. BODY ACHES, CHILLS, FEVER OF 101.5. ALL SYMPTOMS  WITH THE EXCEPTION OF FATIGUE RESOLVED WITHIN 48 HRS OF RECEIVING THE 2ND DOSE
1st COVID vaccine shot was administered in upper left arm. No major side effects within 24 hours except very mild soreness. Within 8 days of the shot, I began to experience red splotchiness/flushing of the skin around the injection site and further beyond that area all around my upper left arm down to upper elbow region as well as significant swelling/edema of the upper arm. I didn't experience pain or tenderness or these symptomns near the lymph nodes/armpit.The redness, tenderness, swelling lasted several days and then slowly went away after 4 days.
Moderna COVID-19 vaccine EUA I was administed the covid vaccine around 4:05 pm and at approximately 1230 am, I started to feel nauseous and did vomit once. Today (day after vaccine)I still feel nauseous, extra fatigue,joint pain (mainly hips and knees)  body aches, chills, and sore arm at the injection site.
Rash/itchiness began around the injection site. Rash and redness began appearing in various areas of my arms, legs and torso. Rash accompanied by intense itching. I went to the Emergency Room. The Dr. and staff took my vitals and gave me Prednisone and Benadryl.
Information has been received from a physician concerning a 60 year old male patient with diabetes, hypertension and dyslipidaemia who on the morning of 01-DEC-2008 was vaccinated with a first dose of ZOSTAVAX (lot # 663197/1418X) in his left arm. Concomitant therapy included AVAPRO, CALAN SR, LIPITOR and cyclobenzaprine HCl (MSD). The physician reported that the patient woke up 48 hours after vaccination with hearing loss, developed severe earache, slight sore throat with fever, moderate earache. The patient saw an ear, nose and throat (ENT) specialist, then developed hyperacusis. Saw ENT in follow up. Hearing bad to non existent. The physician stated that she didn't have any correspondence from ENT. Additional information has been requested.
pt recv vax 14AUG96 & 21AUG96 pt exp scattered rash on mid thighs to mid calfs which was sl itchy;pt recovered;
This spontaneous report was received from a 73 year old female patient, regarding herself. Her concomitant therapies included ZIOPTAN. The patient's concurrent conditions and medical history were not reported. Approximately in 2011 (reported as "about 4-6 years ago"), the patient was vaccinated with ZOSTAVAX route reported as "injection" (concentration, dose, frequency and anatomical place of vaccination were not reported), for prophylaxis. Other suspect therapies included sterile diluent. On 18-AUG-2017, the patient developed shingles even though she had received ZOSTAVAX. Therefore, she received an unspecified treatment. At the time of the reporting, the outcome of vaccination failure was unknown and the reporter did not provide a causality assessment between ZOSTAVAX and vaccination failure. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1709USA004175: US-009507513-1709USA004176.
Has red know on arm at injection, sore area (also has irritated area on the inner part of elbow, not sure if related).
Symptoms appeared about two weeks after the shot. Shortness of breath, pressure on my heart, pressure on my lungs, who body feels weak.   I have not treatments yet.
SARS-COV-2 RNA RESP QL NAA+PROBE performed on 7/20/21 at 14:56. Came back detected. Case investigation interview with patient has not been performed as of the time of this note.
Systemic: Headache-Severe, Systemic: Nausea-Severe, Additional Details: patient stated vomiting of bile lasted about 9 hours. no medication taken to relieve symptoms and no doctor visit
On 01/26/21, developed visual disturbance to lateral part of left eye with focal blurriness and red color around objects that lasted approximately 1 hour.  On 02/16/21, developed severe neck pain and lightheadedness. Symptoms of lightheadedness, left arm pain, left shoulder pain, neck pain, and numbness/tingling in left hand continue to present. On 03/31/21, visual disturbance returned to lateral part of left eye with zigzagging patterns and blurriness.  Treatment initiated on 04/01/21 with cyclobenzaprine 10mg oral daily. Prednisone initiated on 04/05/21 with 40mg oral daily x 3 days and 20mg oral daily x 3 days.
not feeling well; tired; This is a spontaneous report from a non-contactable consumer. A female patient of unknown age received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 28Apr2021, as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. It was unknown if the patient received any other vaccines within four weeks prior to the COVID vaccine. On an unknown date in Apr2021, the patient was not feeling well and tired. The clinical outcome of the event not feeling well and tired was unknown at the time of reporting.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected
Soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced VACCINATION SITE PAIN (Soreness at the injection site). At the time of the report, VACCINATION SITE PAIN (Soreness at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The concomitant medications were not provided The treatment information was not  provided
7/22/2021  Child collapsed on soccer field while playing soccer at a local camp.  CPR was initiated immediately.  EMS arrived and found patient in vtac.  Shock x 5.  ACLS, intubation attempted.  Transported to Medical Center.  Patient had covid in April 2021.  Dx in May 2021 hypertrophic cardiomyopathy.  Started on lopressor 25mg BID.  Patient had reported to parents that he had not recently taken his medications.  Patient had his second covid vaccine on Sunday 7/18/2021.
45 minutes later, developed angioedema of face and lips.  Airway patent.  Rash on left flank. Was given 50 mg of Benadryl PO and sent out 911.  Returned with orders for Prednisone 50 mg for 5 days.
- (L) arm extremely swollen and sore. - Flu-like symptoms ("couldn't get out of bed") for 3 days. - Still "doesn't feel good".
Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Medium, Additional Details: APPROX. 45 MINUTES AFTER VACCINATION PATIENT NOTIED DIFF SWALLOW AT WORK. TOOK 1 BEN AT 10:40 AND ONE AT 11:15. DID NOT GET WORSE, RECOMMENDED ER, ER SAID AIRWAY WAS OKAY TO ONLY LET THEM KNOW IF IT GOT WORSE.
Pt died on 2/15/22. Pt developed acute bradycardia then PEA. 3 rounds of ACLS given with inability to obtain ROSC.  * There is no lot number entered into database for pts COVID vaccination.
Fatigue; mild to overwhelming nausea, with or without accompanying frontal /facial headache. Totally different from a typical migraine for me. Not associated or affected by food intake. Worsened by heat and odors, and I will vomit or dry heave, depending on if I have eaten. I usually rarely vomit. .... Appetite is very subdued... Usually very good, and I have lost weight (10 pounds... Although I need to!) I am a former RN... So I recognize that this is 'different' than just a passing illness.
5PM on 20AUG91 temp 104, APAP given & cool baths; temp down to 102; 23AUG91 generalized rash resembling "prickly heat"  per mom; Mom reports legs stiff;
Pfizer-BioNTech COVID- 19 Vaccine EUA:   Vaccine recipient?s wife reported that she notice he was slurring his speech and had some confusion prior to getting vaccinated. They contemplated seeking medical care but wanted to get the vaccinated first. After receiving the vaccine, the vaccine recipient was reported to have fell back in his chair and began seizing. EMS responded and treated the patient. They have no history of seizures.  They were transported to emergency department at e Regional Medical Center. The patient was admitted to the intensive care unit for further work up and currently present.
Started with nausea and headache  in 5 hours. Severe chills  and fever in 12 hours which lasted for 24 hours. Took Tylenol to treat it.
Information has been received from a physician concerning a female who was vaccinated with a first dose of GARDASIL without any reactions and on 08-JAN-2009 was vaccinated with second dose of GARDASIL. Concomitant therapy included PLAN B which was given on 07-JAN-2009. Subsequently the patient experienced hives and rash. The patient was seen at the physician's office. At the time of reporting, the patient's hives and rash persisted. Additional information has been requested. This is in follow-up to report(s) previously submitted on 02/13/09. No further information was available.
Client received the vaccine at approximately 0910 and was seated in the "monitoring" area for 15 minutes; client left the vaccine clinic and at around 9:50am a tingling sensation started at jaw, lips and face; immediately after her tongue became swollen and throat was tight; cold sweats and client was pale according to spouse, began shaking; immediately after throat was swollen and was drooling; quickly after her tongue was no longer swollen and she could then swallow and only felt numbness in her mouth; she reached the ER at 9:56 am and at that time she only had the numbness in mouth and was very shaky.
RACING HEART (HEART STUFF WAS AWFUL); HIGH BLOOD PRESSURE; PAIN; UNCONTROLLABLE SHAKING; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received COVID-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced racing heart (heart stuff was awful), high blood pressure, pain, and uncontrollable shaking. Laboratory data (dates unspecified) included: Blood pressure (NR: not provided) High. The action taken with COVID-19 vaccine ad26.cov2.s was not applicable. The patient recovered from racing heart (heart stuff was awful), and high blood pressure, and the outcome of pain and uncontrollable shaking was not reported. This report was non-serious.
Pt states she received the Covid vaccine on Monday 1/25/21.  She says Mon pm, she started itching all over.  She says her face was also red and blotchy.  She took a Benadryl and that helped.  She says her itchiness has continued since then and she has had to keep taking Benadryl to control it.  She denies any breathing problems, no swelling in mouth, tongue or throat.  She says there was no rx at the injection site, just typical soreness.
Pt recvd first set of vax on 6MAY92 p/a check up; devel t103 around noon & slept all day long until around 445PM-5PM; when woke felt very warm w/eyes looking glase & arms & legs shaking;
At 8:45 am, child received 3 vaccines - flu, varicella and Tdap.  Following administration of 3rd, patient fainted sideways onto table slowly.  Layed on side for approx 10-15 sec, color pink, shaking/tremors in amrs, then sat up again and stated "did I pass out".  MD in at 8:50 am.  Child stated she did not eat breakfast, frozen pop given.  Also c/o right arm numbness, cold pack applied to Tdap shot area.  Child layed down for 20 min.  Glucos at 9:25 am was 97 and BP 104/80, sat up and dressed without incident.  Moving right arm without problems and stated that numbness was resolved.  Reexamined by MD and discharged home with instructions